Document is current
Any future updates will be listed below
-
Authors
Banken, E.
Borg, M.
van Hellemond, I. E. G.
van Ravensteijn, S. G.
Peulen, H. M. U.
Verrijssen, A. E.
Nederend, J.
Daniels-Gooszen, A. W.
van Oudheusden, T. R.
van Lijnschoten, G.
Bloemen, J. G.
Rutten, H. J. T.
van Westreenen, H. L.
de Groot, J. W. B.
Verhoef, C.
Tanis, P. J.
Grotenhuis, B. A.
Aalbers, A. G. J.
Werter, I. M.
Hartogh, M. D. den
Douma, J. A. J.
Calon, T. G. A.
Iersel, L. B. J. Valkenburg-van
Beets, G. L.
Tuynman, J. B.
Intven, M. P. W.
van Kuijk, S. M. J.
Berbée, M.
Buffart, T. E.
Roodhart, J. M. L.
Burger, J. W. A.
,
-
Funding
Funding for this research was provided by:
ZonMw (11320102410057)
- License Information
-
More Information
Article History
Received: 16 March 2026
Accepted: 20 April 2026
First Online: 18 May 2026
Declarations
:
: This research is centrally approved by the Dutch Competent Authority (CCMO, The Hague, the Netherlands) and the Medical Research Ethics Committees United (MEC-U, Nieuwegein, the Netherlands), on the fourth of February 2026, with EU-CT number 2025–523692-00.All significant protocol amendments will be submitted to the competent authority, the medical research ethics committee, the institutional review boards of all participating study centres, the (principal) investigators, and the trial registries.Informed consent will be obtained before any study-related procedures during screening. The consent will be written, dated, and signed by both the interviewer and the participant. The investigator or a representative will explain the study and address any questions. The participant's understanding will be verified during the interview. A copy of the signed consent document will be provided to the participant, and consent will be properly documented. Sufficient time will be allowed for the participant to consider their decision to participate.
: Not applicable.
: The authors declare no competing interests.
